Previous 10 | Next 10 |
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, today announced the appointment of Dr. Terri Hunter...
Data confirm the positive topline results announced in December 2021 demonstrating AL001 in plasma is bioequivalent to the marketed lithium carbonate product Results show that the shapes of the lithium plasma concentration versus time curves are similar to marketed pro...
Shares of Alzamend Neuro (ALZN +17.6%) are significantly higher today after a 10%+ owner of shares added to holdings. An SEC filing indicates that Milton Ault III, through Ault Alpha LP, purchased 100K shares at $1.1045 per share for a total value of $110,450. The filing also indicates that A...
Gainers: JX Luxventure (LLL) +214%. Draganfly (DPRO) +83%. Zhangmen Education (ZME) +64%. Antelope Enterprise Holdings Limited (AEHL) +37%. Society Pass (SOPA) +31%. Ever-Glory International Group (EVK) +33%. iQIYI (IQ) +26%. Alzamend Neuro (ALZN) +23%. FreightCar America (RAIL) +24%. Puxin (...
Gainers: TCR2 Therapeutics (TCRR) +16%. Precision BioSciences (DTIL) +16%. Alzamend Neuro (ALZN) +15%. BioSig Technologies (BSGM) +13%. Applied Therapeutics (APLT) +13%. Losers: ORIC Pharmaceuticals (ORIC) -29%. Applied Genetic Technologies (AGTC) -28%. NeuroSense Therapeutics (NRSN...
Draganfly DPRO +82% on order for lifesaving drones from Revived Soldiers Ukraine. Troika Media (TRKA) +43%. Enservco (ENSV) +28%. Alzamend Neuro (ALZN) +23%. Kaixin Auto KXIN +18% on new energy logistics vehicles order from Beijing Bujia. Zhihu (ZH) +13%. FreightCar Americ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Grab your cup of coffee, investor! We’re starting off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: ventdusud / Shutterstock.com Penny stocks are a hot topic today with man...
Are These Penny Stocks on Your January 2021 Small-Caps List? With penny stocks continuing to trend in the last few weeks, investors are searching for the best small-caps to buy. And, as we barrel toward the end of the year, more traders than ever are looking for ways to make money wit...
Alzamend reported positive results from its phase 1 study using AL001 for the treatment of patients with Alzheimer's Disease. The phase 2 multiple ascending dose study using AL001 treating this patient population is expected to begin Q2 of 2022. AL002 is another shot on goal targe...
What To Know In The Stock Market Today It’s been a long week this week, thanks to wild volatility in the stock market. Today is no different as broader markets pullback. Inflation, virus fears, and interest rate concerns have shaken investors globally. Fears Persist Thanks To...
News, Short Squeeze, Breakout and More Instantly...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical compa...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...